The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic Disease
NCT01143493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 278
Last updated 2019-12-04
Summary
Background:
\- Glucocorticoids are primary stress response hormones released from the adrenal gland when an individual is under stress. Chronic or ongoing elevation of these hormones due to prolonged stress or medical treatments can have numerous harmful effects. Researchers are interested in learning more about how these hormones affect cell growth, development, and death. To study glucocorticoid hormones, researchers plan to use the medication dexamethasone, which affects the parts of cells that respond to glucocorticoid hormones.
Objectives:
\- To study glucocorticoid stress hormones in healthy individuals before and after receiving dexamethasone.
Eligibility:
* Healthy individuals at least 18 years of age.
* Participants must not be using certain medications that may affect the dexamethasone test, including hormonal contraception, steroid-based drugs, and some antidepressants.
Design:
* This study will require an initial screening visit and a second study visit. The visits are estimated to require about 1 to 2 hours of participation over a period of up to 14 days.
* Participants will be screened at visit 1 with a full physical examination and medical history, and an initial blood sample for testing.
* For visit 2, participants will be asked to abstain from all food and drinks except for water for 12 hours before the appointment, and will take one tablet of dexamethasone 9 hours before the appointment.
* Participants will have a second blood sample taken during visit 2, and will receive a snack after the blood is drawn.
Conditions
- Glucose Homeostasis
- Protein Metabolism
- Lipid Metabolism
- Respiratory Function
- Connective Tissue Metabolism
Sponsors & Collaborators
-
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Principal Investigators
-
Stavros Garantziotis, M.D. · National Institute of Environmental Health Sciences (NIEHS)
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-09-30
- Primary Completion
- 2019-12-02
- Completion
- 2019-12-02
Countries
- United States
Study Locations
More Related Trials
-
Observational Study to Characterize Biomarkers and Disease Progression in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
NCT06014541 ·Status: TERMINATED
-
Inherited Reproductive Disorders
NCT01500447 ·Status: RECRUITING
-
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
NCT00001452 ·Status: COMPLETED
-
NIEHS Repository of Stored Biological Samples for Future Use
NCT05666739 ·Status: RECRUITING
-
Genetics of Motor Learning
NCT01105845 ·Status: TERMINATED
-
Next Generation to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols
NCT01375543 ·Status: COMPLETED
-
Study of Clinical and Molecular Manifestations of Genetic Disorders
NCT00001466 ·Status: COMPLETED
-
Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children
NCT00010114 ·Status: COMPLETED
-
Effect of Functional Genetic Polymorphisms on Brain Morphology and Function
NCT01035723 ·Status: COMPLETED
-
Adult Patients With Undiagnosed Conditions and Their Responses to Clinically Uncertain Results From Exome Sequencing
NCT03605004 ·Status: COMPLETED
-
Uncertain Genetic Test Results for Lynch Syndrome
NCT01646112 ·Status: COMPLETED
-
Observational Study of Advanced Data Analytics in Genetic Conditions
NCT05657405 ·Status: RECRUITING
-
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
NCT03160274 ·Status: RECRUITING
-
Diagnostic and Screening Study of Genetic Disorders
NCT00006057 ·Status: COMPLETED
-
GWAS Identified Susceptibility Loci for Glucocorticoid-induced FHN in the Chinese Population
NCT02365077 ·Status: UNKNOWN
-
A Study to Compare Genetic Variations of IGF-I and IGF-II
NCT01329523 ·Status: COMPLETED
-
NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing
NCT01969370 ·Status: COMPLETED ·Phase: NA
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
NCT02450851 ·Status: RECRUITING
-
A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
NCT06092346 ·Status: RECRUITING
-
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
NCT04199000 ·Status: RECRUITING
-
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
NCT04888936 ·Status: RECRUITING
-
Genes Involved in Lipid Disorders
NCT02311335 ·Status: COMPLETED
-
Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
NCT00406445 ·Status: COMPLETED
-
Genes of Hypertension in African Americans
NCT00063505 ·Status: COMPLETED
-
Genetic Study of Patients With Primary Ciliary Dyskinesia
NCT00005650 ·Status: COMPLETED